Low CD4+ combined with low CD8+ may suggest a lesser but effective and balanced anti-cancer immune activation that could lead to a better OS; in contrast, high CD4+ combined with low CD8+ TIL levels may be related to a suppressed cellular immune response and consequently to worse outcomes. This evidence concerns the gene CD4 and cancer.